Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers Isn’t in Talks for Elan Stake, UBS Says
Bloomberg
Monday, June 1, 2009 - 8:03am
tags:
Elan, Bristol-Myers Squibb, buyouts
Anti Inflammatory Topical Treatment Gains Traction
Yahoo/The Wall St. Transcript
Monday, June 1, 2009 - 7:58am
tags:
Pennsaid, Nuvo Research
Bausch & Lomb settles 600 eye fungus lawsuits
Yahoo/AP
Monday, June 1, 2009 - 7:56am
tags:
Bausch & Lomb, settlements
Genentech-ImmunoGen Breast Cancer Drug Shows Effectiveness
TheStreet.com
Monday, June 1, 2009 - 7:55am
tags:
Genentech, Immunogen, breast cancer
Sanofi's Breast Cancer Bet
Forbes
Monday, June 1, 2009 - 7:51am
tags:
Sanofi, breast cancer
Subset Data from Two Randomized Phase 3 Trials Show TYSABRI Significantly Improves Health-Related Quality of Life for Crohn's Disease Patients with Prior Exposure or Inadequate Response to Anti-TNF Therapy
Yahoo/BusinessWire
Sunday, May 31, 2009 - 10:00am
tags:
Elan, Tysabri, Chron's Disease
Investigational Cancer Drug BSI-201 Showed Clinical Benefit in 62% of Patients With Triple-Negative Metastatic Breast Cancer and Significantly Prolonged Survival
Yahoo/Globa News Wire
Sunday, May 31, 2009 - 9:58am
tags:
Sanofi, breast cancer
Merck Sees Erbitux Sales At EUR1B By 2010 or 2011
Wall Street Journal
Sunday, May 31, 2009 - 9:57am
tags:
Merck
Bayer CEO Werner Wenning: „Bayer is well positioned for the future“
PRdomain Business Register
Sunday, May 31, 2009 - 9:52am
tags:
Bayer
Get Latest Quote and Company Info Sun Pharma fourth-quarter net falls 45% to Rs 394 cr
Hindu Business Line, India
Sunday, May 31, 2009 - 9:49am
tags:
Sun Pharma
Caraco Pharma Poised for a Turnaround 3 comments
Seeking Alpha
Sunday, May 31, 2009 - 9:35am
tags:
Caraco
Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
Yahoo/PR NewsWire
Sunday, May 31, 2009 - 9:31am
tags:
Keryx, colon cancer
Results from Three Phase 2 Studies Reported a Two-Year Survival Rate Ranging from 30 to 42 Percent in Metastatic Melanoma Patients Treated with Ipilimumab (10 mg/kg)
Yahoo/BusinessWire
Sunday, May 31, 2009 - 9:30am
tags:
Cougar Biotechnology Presents Positive CB7630 (Abiraterone Acetate) Phase II Data at ASCO Annual Meeting
Yahoo/BusinessWire
Sunday, May 31, 2009 - 9:29am
tags:
Cougar Biotechnology
Exelixis and BMS Report Phase 2 Data to Be Presented at ASCO for XL184 in Patients with Previously Treated Glioblastoma Multiforme
Yahoo/BusinessWire
Sunday, May 31, 2009 - 9:27am
tags:
Exelixis, Bristol-Myers Squibb
Two Potential Mega Biotech Deals Fuel Industry Hopes
Seeking Alpha
Sunday, May 31, 2009 - 9:23am
tags:
biotech, Amgen, Bristol-Myers Squibb, Sanofi, Exelixis
New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer
CNW Telbec, Canada
Saturday, May 30, 2009 - 10:10am
tags:
Wyeth
Pfizer Presents Data With Novel Investigational Agents In Select Patient Groups With Non-Small Cell Lung Cancer
Yahoo/BusinessWire
Saturday, May 30, 2009 - 10:07am
tags:
Pfizer
Cytokinetics Presents Clinical Data Relating to SB-743921 in Patients With Non-Hodgkin or Hodgkin Lymphoma at the 2009 Annual Meeting of the American Society of Clinical Oncology
Yahoo/Marketwire
Saturday, May 30, 2009 - 10:05am
tags:
Cytokinetics
Oncothyreon announces clinical data from three product candidates presented at American Society of Clinical Oncology (ASCO) Annual Meeting
Yahoo/PR NewsWire
Saturday, May 30, 2009 - 10:03am
tags:
Oncothyreon

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.